News | February 26, 2026
Envoy Medical secures three new patents, bolstering cochlear implant leadership
The new patents cover critical advancements in cochlear implant technology
The new patents cover critical advancements in cochlear implant technology
Meenal brings in more than 16 years of international experience across Europe, Asia and the Middle East
Brivaracetam Oral Solution (10 mg/mL) is a prescription antiepileptic drug (anticonvulsant) used for treatment of partial-onset seizures in patients 1 month of age and older
New partnership combines Shilpa Biologicals’ development and manufacturing capabilities with SteinCares’ regional commercialization platform
Sugemalimab, developed using CStone’s OmniRat transgenic platform, is a fully human IgG4 monoclonal antibody designed to minimize immunogenicity and toxicity
The move follows encouraging Phase I data and a series of regulatory wins from the U.S. Food and Drug Administration
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
UBT251 appeared to have a safe and well-tolerated profile consistent with incretin-based therapies
The project entails a total planned capital expenditure of approximately Rs. 500 - 520 crore
BLA is based on a robust data package supporting similarity to Orencia (abatacept) IV for infusion through totality of evidence including pharmacokinetic (PK) data
Subscribe To Our Newsletter & Stay Updated
